NO762489L - - Google Patents
Info
- Publication number
- NO762489L NO762489L NO762489A NO762489A NO762489L NO 762489 L NO762489 L NO 762489L NO 762489 A NO762489 A NO 762489A NO 762489 A NO762489 A NO 762489A NO 762489 L NO762489 L NO 762489L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- formula
- compound
- alkyl
- stated
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 42
- 125000004432 carbon atom Chemical group C* 0.000 claims description 40
- 125000000217 alkyl group Chemical group 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 20
- 239000001257 hydrogen Substances 0.000 claims description 20
- 125000003545 alkoxy group Chemical group 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 17
- 150000002431 hydrogen Chemical class 0.000 claims description 14
- 239000002585 base Substances 0.000 claims description 13
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 11
- 229910052736 halogen Inorganic materials 0.000 claims description 10
- 150000002367 halogens Chemical class 0.000 claims description 10
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 10
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 4
- 229910000102 alkali metal hydride Inorganic materials 0.000 claims description 3
- 150000008046 alkali metal hydrides Chemical class 0.000 claims description 3
- 125000003342 alkenyl group Chemical group 0.000 claims description 3
- 125000000304 alkynyl group Chemical group 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- 229910000104 sodium hydride Inorganic materials 0.000 claims description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims description 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims description 2
- 239000012312 sodium hydride Substances 0.000 claims description 2
- 150000003512 tertiary amines Chemical class 0.000 claims description 2
- OJKBJZARYADLNR-UHFFFAOYSA-N 6-chloro-4-hydroxy-3-nitro-1-prop-2-ynylquinolin-2-one Chemical compound C1=C(Cl)C=C2C(O)=C([N+]([O-])=O)C(=O)N(CC#C)C2=C1 OJKBJZARYADLNR-UHFFFAOYSA-N 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- -1 potassium hydrides Chemical class 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 4
- 150000008040 ionic compounds Chemical class 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- SHZUGBYEPDMAPC-UHFFFAOYSA-N 4-hydroxy-3-nitro-1h-quinolin-2-one Chemical class C1=CC=C2C(=O)C([N+]([O-])=O)=C(O)NC2=C1 SHZUGBYEPDMAPC-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229960000265 cromoglicic acid Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- FTKASJMIPSSXBP-UHFFFAOYSA-N ethyl 2-nitroacetate Chemical compound CCOC(=O)C[N+]([O-])=O FTKASJMIPSSXBP-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59853975A | 1975-07-23 | 1975-07-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO762489L true NO762489L (sv) | 1977-01-25 |
Family
ID=24395967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO762489A NO762489L (sv) | 1975-07-23 | 1976-07-15 |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS5225781A (sv) |
| AU (1) | AU1620976A (sv) |
| BE (1) | BE844414A (sv) |
| DD (1) | DD126769A5 (sv) |
| DE (1) | DE2631317A1 (sv) |
| DK (1) | DK319276A (sv) |
| ES (1) | ES450060A1 (sv) |
| FI (1) | FI762046A (sv) |
| FR (1) | FR2318633A1 (sv) |
| IL (1) | IL50090A0 (sv) |
| NL (1) | NL7607968A (sv) |
| NO (1) | NO762489L (sv) |
| NZ (1) | NZ181532A (sv) |
| PT (1) | PT65391B (sv) |
| SE (1) | SE7608151L (sv) |
| YU (1) | YU181176A (sv) |
| ZA (1) | ZA764449B (sv) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130587A (en) * | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
| IE52656B1 (en) * | 1981-04-07 | 1988-01-06 | Shell Int Research | Closure device |
| JPS60101445U (ja) * | 1983-12-17 | 1985-07-10 | 紀伊産業株式会社 | 密封容器 |
| JPH0621181B2 (ja) * | 1987-01-12 | 1994-03-23 | テルモ株式会社 | 親水性ポリフッ化ビニリデン多孔質膜の製造方法 |
| JPH0644827Y2 (ja) * | 1988-09-20 | 1994-11-16 | エヌオーケー株式会社 | キャップ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1770482A1 (de) * | 1968-05-22 | 1971-11-11 | Basf Ag | Verfahren zur Herstellung von 2,4-Dioxychinolinen |
| NL7314812A (sv) * | 1972-11-02 | 1974-05-06 | ||
| GB1453863A (en) * | 1973-05-19 | 1976-10-27 | Beecham Group Ltd | Pharmaceutical compositions comprising nitrocarbostyrils for the treatment of allergic and immunological hypersensitivity |
-
1976
- 1976-07-12 DE DE19762631317 patent/DE2631317A1/de active Pending
- 1976-07-14 DK DK319276A patent/DK319276A/da unknown
- 1976-07-14 FI FI762046A patent/FI762046A/fi not_active Application Discontinuation
- 1976-07-15 NO NO762489A patent/NO762489L/no unknown
- 1976-07-16 SE SE7608151A patent/SE7608151L/sv unknown
- 1976-07-19 NL NL7607968A patent/NL7607968A/xx unknown
- 1976-07-21 NZ NZ181532A patent/NZ181532A/xx unknown
- 1976-07-21 IL IL50090A patent/IL50090A0/xx unknown
- 1976-07-21 PT PT65391A patent/PT65391B/pt unknown
- 1976-07-21 DD DD193994A patent/DD126769A5/xx unknown
- 1976-07-21 JP JP51086079A patent/JPS5225781A/ja active Pending
- 1976-07-22 ES ES450060A patent/ES450060A1/es not_active Expired
- 1976-07-22 YU YU01811/76A patent/YU181176A/xx unknown
- 1976-07-22 BE BE169152A patent/BE844414A/xx unknown
- 1976-07-23 FR FR7622494A patent/FR2318633A1/fr active Granted
- 1976-07-23 ZA ZA00764449A patent/ZA764449B/xx unknown
- 1976-07-23 AU AU16209/76A patent/AU1620976A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IL50090A0 (en) | 1976-09-30 |
| FR2318633A1 (fr) | 1977-02-18 |
| DK319276A (da) | 1977-01-24 |
| ES450060A1 (es) | 1977-12-01 |
| PT65391A (fr) | 1976-08-01 |
| YU181176A (en) | 1982-05-31 |
| PT65391B (fr) | 1978-04-05 |
| BE844414A (fr) | 1977-01-24 |
| AU1620976A (en) | 1978-01-26 |
| DD126769A5 (sv) | 1977-08-10 |
| SE7608151L (sv) | 1977-01-24 |
| NZ181532A (en) | 1978-07-10 |
| DE2631317A1 (de) | 1977-02-17 |
| FR2318633B1 (sv) | 1978-12-22 |
| JPS5225781A (en) | 1977-02-25 |
| NL7607968A (nl) | 1977-01-25 |
| FI762046A (sv) | 1977-01-24 |
| ZA764449B (en) | 1978-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1543002E (pt) | Preparação de intermediários 1h-imidazo ( 4,5-c )quinolin-4-aminas via 1h- imidazo (4,5-c ) quinolina-4-ftalimida | |
| NO169437B (no) | 3-amino-kinoliner. | |
| KR930002492B1 (ko) | 6-티오크산틴 유도체의 제조방법 | |
| HU217080B (hu) | Új eljárás imidazo[4,5-c]kinolin-4-amin-származékok előállítására | |
| HU219911B (hu) | Pirazolo-piridin-származékok, alkalmazásuk és ezeket tartalmazó gyógyászati készítmények | |
| EP0070562B1 (en) | Ergoline derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DK146205B (da) | Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater | |
| CN118076586A (zh) | Kif18a抑制剂 | |
| EP0081756B1 (en) | New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions | |
| NO762489L (sv) | ||
| US4127574A (en) | 4-Hydroxy-3-sulfonyl-quinolin-2(1H)-ones | |
| US4124587A (en) | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones | |
| JPS6354363A (ja) | キノリン誘導体 | |
| NO752972L (sv) | ||
| CN109851599B (zh) | 一种2-氨基苯并呋喃化合物的制备方法 | |
| NO743980L (sv) | ||
| US3936459A (en) | 1',4'-Dihydro-1-methyl-spiro [piperidine and pyrrolidine-2,3'(2'H)quinoline]-2'-one compounds | |
| EP0977757B1 (en) | 9,10-diazatricyclo 4.2.1.1?2,5 ]decane and 9,10-diazatricyclo 3.3.1.1?2,6 ]decane derivatives having analgesic activity | |
| CN111233750A (zh) | 一种3,3-二氟-1,2,3,6-四氢哌啶类衍生物及其制备方法 | |
| NO751063L (sv) | ||
| DK156574B (da) | Fremgangsmaade til fremstilling af et racemisk eller optisk aktivt 15-hydroxyimino-e-homoeburnanderivat eller syreadditionssalte deraf | |
| US3939167A (en) | 3-(2-Methylthio-2-tertiary aminoacetyl)-5-phenylisoxazoles | |
| NO761937L (sv) | ||
| JPH04169583A (ja) | フェノチアジン誘導体およびその製造方法 | |
| EP0203697A1 (en) | A process for preparing substituted anthra[1,9-od]pyrazol-6(2H)-ones |